CRYOPORT, INC. Earnings Per Share, Basic and Diluted
CRYOPORT, INC. (CYRX) reported Earnings Per Share, Basic and Diluted of -$5.46 per share for the 3-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-28
- CRYOPORT, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$5.46.
- CRYOPORT, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.18.
- CRYOPORT, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.16.
- CRYOPORT, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.13.
- CRYOPORT, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.94.
- CRYOPORT, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.55.
- CRYOPORT, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.34.
- CRYOPORT, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.34.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$5.46 10-K · filed 2022-02-28 | |||||||
| 2021-09-30 | -$0.18 10-K · filed 2022-02-28 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.48 10-Q · filed 2021-11-04 | -$1.72 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-06-30 | -$0.16 10-K · filed 2022-02-28 | -$0.29 10-Q · filed 2021-08-06 | -$1.55 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-03-31 | -$0.13 10-K · filed 2022-02-28 | -$1.43 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.91 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2020-12-31 | -$1.32 10-K · filed 2022-02-28 | -$1.66 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.82 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.94 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | -$0.29 10-K · filed 2022-02-28 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.55 10-Q · filed 2021-11-04 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2020-06-30 | -$0.15 10-K · filed 2022-02-28 | -$0.26 10-Q · filed 2021-08-06 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2020-03-31 | -$0.11 10-K · filed 2022-02-28 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.48 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2019-12-31 | -$0.03 10-K · filed 2022-02-28 | -$0.37 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.55 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | -$0.35 10-K · filed 2022-02-28 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.54 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | -$0.08 10-K · filed 2022-02-28 | -$0.16 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | -$0.08 10-K · filed 2022-02-28 | |||||||
| 2018-12-31 | -$0.08 10-K · filed 2020-03-10 | -$0.34 10-K · filed 2020-03-10 | ||||||
| 2018-09-30 | -$0.07 10-K · filed 2020-03-10 | -$0.26 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.09 10-K · filed 2020-03-10 | -$0.19 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$0.10 10-K · filed 2020-03-10 | |||||||
| 2017-12-31 | -$0.09 10-K · filed 2019-03-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-03-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2019-03-13 | -$0.34 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$0.08 10-K · filed 2019-03-13 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$0.25 10-Q · filed 2018-11-08 | -$0.48 derived: net income ÷ weighted average shares · filed 2018-11-08 | ||||
| 2017-06-30 | -$0.08 10-K · filed 2019-03-13 | -$0.18 10-Q · filed 2018-08-09 | -$0.41 derived: net income ÷ weighted average shares · filed 2018-08-09 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-08-09 | ||||
| 2017-03-31 | -$0.10 10-K · filed 2019-03-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2018-05-03 | -$0.50 derived: net income ÷ weighted average shares · filed 2018-05-03 | -$0.76 derived: net income ÷ weighted average shares · filed 2018-05-03 | ||||
| 2016-12-31 | -$0.25 10-K · filed 2018-03-08 | -$0.40 derived: net income ÷ weighted average shares · filed 2018-03-08 | -$0.68 10-K · filed 2018-03-08 | -$0.93 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | -$0.14 10-K · filed 2018-03-08 | -$0.42 10-Q · filed 2016-11-14 | -$0.67 10-Q · filed 2017-11-02 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-11-02 | ||||
| 2016-06-30 | -$0.28 10-K · filed 2018-03-08 | -$0.54 10-Q · filed 2017-08-09 | -$0.91 derived: net income ÷ weighted average shares · filed 2017-08-09 | -$1.29 derived: net income ÷ weighted average shares · filed 2017-08-09 | ||||
| 2016-03-31 | $0.00 10-K · filed 2018-03-08 | -$0.26 10-K · filed 2016-06-28 | -$0.65 derived: net income ÷ weighted average shares · filed 2017-05-04 | -$1.04 derived: net income ÷ weighted average shares · filed 2017-05-04 | -$2.05 10-KT · filed 2017-03-13 | |||
| 2015-12-31 | -$0.42 10-KT · filed 2017-03-13 | -$0.83 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$1.96 10-KT · filed 2017-03-13 | -$2.73 derived: net income ÷ weighted average shares · filed 2016-11-14 | ||||
| 2015-09-30 | -$0.41 10-KT · filed 2017-03-13 | -$1.61 10-Q · filed 2016-11-14 | -$2.39 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$2.82 derived: net income ÷ weighted average shares · filed 2016-11-14 | ||||
| 2015-06-30 | -$1.31 10-KT · filed 2017-03-13 | -$2.10 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$2.50 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$3.13 derived: net income ÷ weighted average shares · filed 2016-08-15 | ||||
| 2015-03-31 | -$0.26 10-KT · filed 2017-03-13 | -$0.79 10-K · filed 2015-05-19 | -$1.19 derived: net income ÷ weighted average shares · filed 2016-06-28 | -$1.82 derived: net income ÷ weighted average shares · filed 2016-06-28 | -$2.44 10-K · filed 2016-06-28 | |||
| 2014-12-31 | -$0.40 10-K · filed 2016-06-28 | -$0.03 10-Q · filed 2015-02-05 | -$1.04 derived: net income ÷ weighted average shares · filed 2016-02-11 | -$1.65 10-Q · filed 2016-02-11 | -$0.14 10-Q · filed 2015-02-05 | $0.37 derived: net income ÷ weighted average shares · filed 2016-02-11 | ||
| 2014-09-30 | -$0.64 10-K · filed 2016-06-28 | -$0.05 10-Q · filed 2014-11-12 | -$1.25 10-Q · filed 2015-11-16 | -$0.10 10-Q · filed 2014-11-12 | $0.21 derived: net income ÷ weighted average shares · filed 2015-11-16 | $0.75 derived: net income ÷ weighted average shares · filed 2015-11-16 | ||
| 2014-06-30 | -$0.61 10-K · filed 2016-06-28 | -$0.05 10-Q · filed 2014-07-31 | $0.08 derived: net income ÷ weighted average shares · filed 2015-08-06 | $0.34 derived: net income ÷ weighted average shares · filed 2015-08-06 | $5.12 derived: net income ÷ weighted average shares · filed 2015-08-06 | |||
| 2014-03-31 | -$0.29 10-K · filed 2015-05-19 | -$0.02 10-K · filed 2014-06-25 | $0.11 derived: net income ÷ weighted average shares · filed 2015-05-19 | $2.53 derived: net income ÷ weighted average shares · filed 2015-05-19 | -$4.81 10-K · filed 2015-05-19 | -$0.40 10-K · filed 2014-06-25 | ||
| 2013-12-31 | -$0.37 10-K · filed 2015-05-19 | -$0.03 10-Q · filed 2014-02-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2015-02-05 | -$0.40 10-Q · filed 2015-02-05 | ||||
| 2013-09-30 | -$4.59 10-K · filed 2015-05-19 | -$0.38 10-Q · filed 2013-11-18 | -$0.42 10-Q · filed 2014-11-12 | |||||
| 2013-06-30 | -$0.42 10-K · filed 2015-05-19 | -$0.03 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | -$0.05 10-K · filed 2014-06-25 | -$0.17 10-K · filed 2014-06-25 | ||||||
| 2012-12-31 | -$0.04 10-K · filed 2014-06-25 | -$0.12 10-Q · filed 2014-02-13 | ||||||
| 2012-09-30 | -$0.04 10-K · filed 2014-06-25 | $0.04 10-Q · filed 2012-11-09 | -$0.08 10-Q · filed 2013-11-18 | |||||
| 2012-06-30 | -$0.04 10-K · filed 2014-06-25 | |||||||
| 2012-03-31 | -$0.27 10-K · filed 2013-06-25 | |||||||
| 2011-12-31 | -$0.07 10-Q · filed 2013-02-14 | -$0.22 10-Q · filed 2013-02-14 | ||||||
| 2011-09-30 | -$0.07 10-Q · filed 2012-11-09 | -$0.15 10-Q · filed 2012-11-09 | ||||||
| 2011-06-30 | -$0.07 10-Q · filed 2012-08-14 | |||||||
| 2011-03-31 | -$0.46 10-K · filed 2012-06-27 | |||||||
| 2010-12-31 | -$0.11 10-Q · filed 2012-02-21 | -$0.40 10-Q · filed 2012-02-21 | ||||||
| 2010-09-30 | -$0.15 10-Q · filed 2011-11-14 | -$0.31 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$0.16 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |